Kelly Lawrence W & Associates’s Medtronic MDT Stock Holding History

Kelly Lawrence W & Associates’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.9K	Hold	600	–	–	0.01%	110
2026 Q1	$52K	Hold	600	–	–	0.01%	103
2025 Q4	$57.6K	Hold	600	–	–	0.01%	104
2025 Q3	$57.1K	Hold	600	–	–	0.01%	110
2025 Q2	$52.3K	Sell	600 -1,550	-72%	-$131K	0.01%	109
2025 Q1	$193K	Hold	2,150	–	–	0.05%	83
2024 Q4	$172K	Hold	2,150	–	–	0.04%	91
2024 Q3	$194K	Hold	2,150	–	–	0.04%	89
2024 Q2	$169K	Hold	2,150	–	–	0.04%	89
2024 Q1	$187K	Hold	2,150	–	–	0.04%	83
2023 Q4	$177K	Hold	2,150	–	–	0.04%	83
2023 Q3	$168K	Hold	2,150	–	–	0.05%	80
2023 Q2	$191K	Hold	2,150	–	–	0.05%	76
2023 Q1	$173K	Buy	+2,150	New	+$175K	0.05%	76
2022 Q4	–	Sell	-6,000	Closed	-$484K	–	173
2022 Q3	$484K	Buy	+6,000	New	+$539K	0.14%	61
2017 Q2	–	Sell	-1	Closed	–	–	172
2017 Q1	$0	Buy	+1	New	+$78	﹤0.01%	201

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Kelly Lawrence W & Associates's MDT Position: Q2 2026 in Review

Kelly Lawrence W & Associates held its Medtronic (MDT) position steady in Q2 2026 at 600 shares worth $46.9K. The position accounts for 0.01% of the portfolio, ranked #110.

Kelly Lawrence W & Associates first reported a position in MDT in Q1 2017 and has held it in 16 quarters since. The position peaked at $484K in Q3 2022. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Kelly Lawrence W & Associates held 600 shares of Medtronic worth $46.9K as of Q2 2026.
Kelly Lawrence W & Associates left its Medtronic share count unchanged in Q2 2026.
Medtronic made up 0.01% of Kelly Lawrence W & Associates's portfolio in Q2 2026, its #110 holding.
Kelly Lawrence W & Associates first reported a position in Medtronic in Q1 2017 and has held it in 16 quarters since.
Kelly Lawrence W & Associates's Medtronic position peaked at $484K in Q3 2022.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.